MX340147B - Composiciones farmacéuticas y nutracéuticas del ácido abscísico. - Google Patents

Composiciones farmacéuticas y nutracéuticas del ácido abscísico.

Info

Publication number
MX340147B
MX340147B MX2014005080A MX2014005080A MX340147B MX 340147 B MX340147 B MX 340147B MX 2014005080 A MX2014005080 A MX 2014005080A MX 2014005080 A MX2014005080 A MX 2014005080A MX 340147 B MX340147 B MX 340147B
Authority
MX
Mexico
Prior art keywords
pharmaceutical
abscisic acid
nutraceutical compositions
compositions
nutraceutical
Prior art date
Application number
MX2014005080A
Other languages
English (en)
Inventor
Maria Pilar Herrero
Warren E Shafer
Original Assignee
Valent Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valent Biosciences Corp filed Critical Valent Biosciences Corp
Publication of MX340147B publication Critical patent/MX340147B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/50—Feeding-stuffs specially adapted for particular animals for rodents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Feed For Specific Animals (AREA)
  • Dairy Products (AREA)

Abstract

La invención se refiere a composiciones que comprenden ácido abscísico, y/o sales, derivados y análogos del mismo, y a métodos de uso farmacéutico y/o nutracéutico.
MX2014005080A 2010-09-17 2011-09-19 Composiciones farmacéuticas y nutracéuticas del ácido abscísico. MX340147B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38402010P 2010-09-17 2010-09-17
PCT/US2011/052173 WO2012037562A2 (en) 2010-09-17 2011-09-19 Pharmaceutical and nutraceutical compositions of abscisic acid

Publications (1)

Publication Number Publication Date
MX340147B true MX340147B (es) 2016-06-28

Family

ID=45818303

Family Applications (7)

Application Number Title Priority Date Filing Date
MX2014005080A MX340147B (es) 2010-09-17 2011-09-19 Composiciones farmacéuticas y nutracéuticas del ácido abscísico.
MX2013002947A MX2013002947A (es) 2010-09-17 2011-09-19 Composiciones de alimento para animales de acido abscisico.
MX2013002949A MX2013002949A (es) 2010-09-17 2011-09-19 Composiciones de acido abscisico para salud animal.
MX2014005078A MX340751B (es) 2010-09-17 2011-09-19 Composiciones de alimento para animales de acido abscisico.
MX2013002948A MX2013002948A (es) 2010-09-17 2011-09-19 Composiciones farmaceuticas y nutraceuticas de acido abscisico.
MX2014005077A MX340752B (es) 2010-09-17 2011-09-19 Composiciones de alimento para animales de acido abscisico.
MX2014005079A MX340983B (es) 2010-09-17 2011-09-19 Composiciones farmaceuticas y nutraceuticas de acido abscisico.

Family Applications After (6)

Application Number Title Priority Date Filing Date
MX2013002947A MX2013002947A (es) 2010-09-17 2011-09-19 Composiciones de alimento para animales de acido abscisico.
MX2013002949A MX2013002949A (es) 2010-09-17 2011-09-19 Composiciones de acido abscisico para salud animal.
MX2014005078A MX340751B (es) 2010-09-17 2011-09-19 Composiciones de alimento para animales de acido abscisico.
MX2013002948A MX2013002948A (es) 2010-09-17 2011-09-19 Composiciones farmaceuticas y nutraceuticas de acido abscisico.
MX2014005077A MX340752B (es) 2010-09-17 2011-09-19 Composiciones de alimento para animales de acido abscisico.
MX2014005079A MX340983B (es) 2010-09-17 2011-09-19 Composiciones farmaceuticas y nutraceuticas de acido abscisico.

Country Status (10)

Country Link
US (9) US20120071557A1 (es)
EP (5) EP2616058B1 (es)
JP (8) JP5898206B2 (es)
CN (6) CN105878224A (es)
BR (4) BR112013005914B1 (es)
CA (2) CA3047772C (es)
DK (1) DK2616059T3 (es)
ES (2) ES2545866T3 (es)
MX (7) MX340147B (es)
WO (3) WO2012037561A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105878224A (zh) * 2010-09-17 2016-08-24 美商华仑生物科学公司 用于动物健康的脱落酸的组合物
CN106132207A (zh) 2014-01-10 2016-11-16 瓦伦特生物科学公司 (s)‑3’‑甲基‑脱落酸及其酯
RU2688347C2 (ru) 2014-07-08 2019-05-21 Вейлент Биосайенс Корпорейшн 3'-замещаемые производные абсцизовой кислоты
WO2016009399A1 (en) 2014-07-17 2016-01-21 NUTRAVIS S.r.l. A new treatment for improving the use of dietary sugar for energy purposes
WO2022131287A1 (ja) * 2020-12-16 2022-06-23 住友化学株式会社 家畜用飼料
PE20240633A1 (es) * 2020-12-16 2024-03-26 Sumitomo Chemical Co Alimento para cerdos mezclado con acido abscisico
TW202245613A (zh) 2021-02-17 2022-12-01 日商住友化學股份有限公司 家畜用飼料
WO2022176902A1 (ja) 2021-02-17 2022-08-25 住友化学株式会社 家畜用飼料
JP2024097094A (ja) 2021-02-17 2024-07-18 住友化学株式会社 家畜用飼料
CN117222325A (zh) 2021-04-07 2023-12-12 住友化学株式会社 家畜用饲料
US20220369630A1 (en) * 2021-05-06 2022-11-24 Stoller Enterprises, Inc. Stable S-(+)-Abscisic Acid Nonaqueous Liquid Solutions

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1182508A (en) 1914-09-05 1916-05-09 Underwood Typewriter Co Automatic type-writer operator.
US1184608A (en) 1915-06-07 1916-05-23 Berger Specialty Mfg Company Inc Bottle-holder.
US3958025A (en) * 1972-10-06 1976-05-18 Livingston Virginia W C Abscisic acid tablets and process
US4434180A (en) 1978-07-28 1984-02-28 Visscher Saralee N Insect control methods with abscisic acid
US4209530A (en) 1978-07-28 1980-06-24 Endowment And Research Foundation At Montana State University Insect control compositions employing abscisic acid
US5834473A (en) * 1993-04-29 1998-11-10 Cultor, Ltd. Method for treating coccidiosis
CA2170142C (en) * 1993-08-27 2010-05-25 Jose M. Wade Composition and method for stimulation of reproductive performance
JP2001181632A (ja) * 1999-10-14 2001-07-03 Nisshin Oil Mills Ltd:The 抗酸化剤
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
US7718699B1 (en) 2005-03-04 2010-05-18 Broyles Robert H Abscissic acid and derivatives thereof for the treatment of diseases
CN100426996C (zh) * 2004-08-02 2008-10-22 阳麈苇 脱落酸抗癌保健饮料
CN1748674A (zh) * 2004-09-14 2006-03-22 中国科学院成都生物研究所 天然脱落酸用于制备肿瘤细胞“分化诱导剂”药物的新用途
JP2006232807A (ja) * 2005-01-27 2006-09-07 Toyobo Co Ltd 西洋わさび抽出物を含む抗酸化剤
CN1686174A (zh) * 2005-04-18 2005-10-26 杨奇彪 防治恶性肿瘤的抑瘤素配方
EP1714673A1 (en) * 2005-04-21 2006-10-25 Desol BV Method for lengthening the mobility period of fish
EP1714674A1 (en) * 2005-04-21 2006-10-25 Desol BV Method for improving the fertility of animals
US20060292215A1 (en) 2005-06-22 2006-12-28 Gonzalo Romero M Abscisic acid against cancer
US8389024B2 (en) * 2005-06-22 2013-03-05 Gonzalo Romero M. Abscisic acid against cancer
ITTO20050708A1 (it) 2005-10-07 2007-04-08 Univ Degli Studi Genova Fluridone come agente anti-infiammatorio
US8367727B2 (en) * 2006-02-08 2013-02-05 Virginia Tech Intellectual Properties, Inc. Method of using abscisic acid to treat diseases and disorders
US7741367B2 (en) * 2006-02-08 2010-06-22 Virginia Tech Intellectual Properties, Inc. Method of using abscisic acid to treat diseases and disorders
JP2008074725A (ja) * 2006-09-19 2008-04-03 Noevir Co Ltd 保湿剤、アルギナーゼ活性促進剤、細胞賦活剤、コラーゲン産生促進剤、ヒアルロン酸産生促進剤、抗酸化剤、及び中性脂肪蓄積抑制剤
JP2009000045A (ja) * 2007-06-21 2009-01-08 Unitika Ltd 飼料配合剤
JP5268086B2 (ja) * 2007-10-02 2013-08-21 国立大学法人岩手大学 冬虫夏草の培養方法及び冬虫夏草を有効成分とする免疫賦活剤、がん細胞増殖抑制剤、抗炎症剤、又は抗酸化剤
US8320308B2 (en) 2007-11-07 2012-11-27 Stmicroelectronics, Inc. Parallel data services and spectrum sensing with cognitive channel switching in a wireless area network
US9063122B2 (en) * 2008-10-17 2015-06-23 Alfredo Gallegos Biomodulators for treatment or prevention of disease
JP5451281B2 (ja) 2009-09-16 2014-03-26 ピーエスフォー ルクスコ エスエイアールエル センスアンプ回路及びそれを備えた半導体装置
WO2011150160A2 (en) * 2010-05-26 2011-12-01 Virginia Tech Intellectual Properties, Inc. Method of preventing and treating inflammatory diseases and disorders with abscisic acid
CN105878224A (zh) * 2010-09-17 2016-08-24 美商华仑生物科学公司 用于动物健康的脱落酸的组合物

Also Published As

Publication number Publication date
EP2616058A1 (en) 2013-07-24
CA3047772A1 (en) 2012-03-22
EP3228311A2 (en) 2017-10-11
US20150250209A1 (en) 2015-09-10
CA3047772C (en) 2021-07-20
EP2616060A4 (en) 2013-10-09
US20220023243A1 (en) 2022-01-27
JP2019031557A (ja) 2019-02-28
ES2545866T3 (es) 2015-09-16
MX340983B (es) 2016-08-01
USRE48854E1 (en) 2021-12-21
DK2616059T3 (en) 2017-10-23
US20120071556A1 (en) 2012-03-22
EP2616060A1 (en) 2013-07-24
CN111494353A (zh) 2020-08-07
BR122019010112B1 (pt) 2021-12-21
EP2616060B1 (en) 2015-08-12
WO2012037561A1 (en) 2012-03-22
CA2809641A1 (en) 2012-03-22
BR112013005912B1 (pt) 2021-07-13
US20140364501A1 (en) 2014-12-11
US20130345308A1 (en) 2013-12-26
ES2545867T3 (es) 2015-09-16
MX2013002948A (es) 2013-05-09
WO2012037563A1 (en) 2012-03-22
CN103179964A (zh) 2013-06-26
EP2616059A2 (en) 2013-07-24
US10238613B2 (en) 2019-03-26
US8536224B2 (en) 2013-09-17
CN105878224A (zh) 2016-08-24
EP3228311A3 (en) 2018-01-10
CN103179965A (zh) 2013-06-26
JP2019163315A (ja) 2019-09-26
US20170143651A1 (en) 2017-05-25
ES2545867T9 (es) 2017-02-17
CN105640929A (zh) 2016-06-08
EP3598970A1 (en) 2020-01-29
BR112013005912A2 (pt) 2016-05-17
US8729122B2 (en) 2014-05-20
MX340752B (es) 2016-07-22
US20120071557A1 (en) 2012-03-22
WO2012037562A3 (en) 2012-08-02
BR112013005915B1 (pt) 2021-10-05
BR112013005914A2 (pt) 2016-05-17
US20120071555A1 (en) 2012-03-22
JP2016166188A (ja) 2016-09-15
JP5898206B2 (ja) 2016-04-06
BR112013005914B1 (pt) 2020-10-06
JP2020019782A (ja) 2020-02-06
JP2023012490A (ja) 2023-01-25
JP6602440B2 (ja) 2019-11-06
CN103179963A (zh) 2013-06-26
EP2616059B1 (en) 2017-07-05
MX2013002947A (es) 2013-05-09
EP2616058A4 (en) 2013-10-09
CA2809641C (en) 2019-09-10
EP2616059A4 (en) 2014-03-26
MX340751B (es) 2016-07-22
JP2013542925A (ja) 2013-11-28
WO2012037562A2 (en) 2012-03-22
US9591867B2 (en) 2017-03-14
EP2616058B1 (en) 2015-08-12
MX2013002949A (es) 2013-05-09
JP2017222688A (ja) 2017-12-21
JP2021075557A (ja) 2021-05-20
BR112013005915A2 (pt) 2016-05-17
JP7217763B2 (ja) 2023-02-03
CN103179964B (zh) 2015-12-02
CN103179963B (zh) 2016-07-06

Similar Documents

Publication Publication Date Title
JOP20180102B1 (ar) مركب صيدلاني
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
MX2013001677A (es) Formulaciones estables de linaclotida.
PH12016501122A1 (en) Delayed release compositions of linaclotide
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
MX2011008864A (es) Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
EP2827869A4 (en) COMPOSITIONS AND METHODS FOR IMPROVING THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ITS ANALOGUES INCLUDING MESOINDIGO
IN2014MN02598A (es)
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
IN2014CN04530A (es)
IL224288A (en) Derivatives of converted pyrazolamide, pharmaceutical preparations containing them and their use
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
PL2768936T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
JO3154B1 (ar) عوامل مضادة لـ trpv4
EA033171B1 (ru) Полутвёрдая фармацевтическая композиция на водной основе, содержащая тапентадол
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2016001422A (es) Composicion farmaceutica de fingolimod.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
EP2452681A4 (en) SALTS OF 13A- (S-) DESOXYTYLPHORININE, METHOD FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF
MX351994B (es) Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico.